Benefit from a clinical trial exome assay with 22,000 clinically relevant genes
The rapidly evolving field of precision medicine is fueling ground-breaking advancements in new disease areas and treatments. Whether you are running clinical trials in Parkinson’s disease, Alzheimer’s disease, cardiovascular disease or other hereditary diseases, precision medicine is continuing to power innovative treatments.
Capitalize on our global partnership with Helix and benefit from a single assay with access to multiple biomarkers for your clinical drug development. The Helix exome assay covers 22,000 clinically relevant genes, including:
Call us during our office hours (Monday to Friday): 800-426-8157
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user operator manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).
This advertisement was sent by QIAGEN. If this email was forwarded to you and you‘d like to receive future communications and advertisements, please sign up here.
